Atomoxetine
NDC 65862-239, Atomoxetine, capsule, from Aurobindo Pharma Limited.
- Product NDC
- 65862-239
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA079016
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATOMOXETINE HYDROCHLORIDE18 mg/1
Pharmacologic classes
Norepinephrine Reuptake Inhibitor [EPC]; Norepinephrine Uptake Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-239-22 | 65862023922 | 2000 CAPSULE in 1 BOTTLE (65862-239-22) |
| 65862-239-30 | 65862023930 | 30 CAPSULE in 1 BOTTLE (65862-239-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6f6bea0c-297b-43ff-8960-ecc11243e06e
Use it
Look up 65862-239 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-239 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-239. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.